vs
Outset Medical, Inc.（OM）とSilvercrest Asset Management Group Inc.（SAMG）の財務データ比較。上の社名をクリックして会社を切り替えられます
Silvercrest Asset Management Group Inc.の直近四半期売上が大きい（$32.0M vs $28.9M、Outset Medical, Inc.の約1.1倍）。Silvercrest Asset Management Group Inc.の純利益率が高く（-0.4% vs -67.5%、差は67.1%）。Silvercrest Asset Management Group Inc.の前年同期比売上増加率が高い（-0.0% vs -2.0%）。Silvercrest Asset Management Group Inc.の直近四半期フリーキャッシュフローが多い（$15.0M vs $-9.7M）。過去8四半期でSilvercrest Asset Management Group Inc.の売上複合成長率が高い（2.7% vs 1.2%）
Outset Medical, Inc.は腎臓病患者向けの革新的な透析ソリューションを開発・商用化する医療テクノロジー企業です。主力製品であるTablo血液透析システムは急性期医療施設、外来クリニック、在宅での使用に対応し、米国及び一部の国際市場の医療機関と患者にサービスを提供しています。
OM vs SAMG — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $28.9M | $32.0M |
| 純利益 | $-19.5M | $-120.0K |
| 粗利率 | 42.4% | — |
| 営業利益率 | -61.1% | -2.8% |
| 純利益率 | -67.5% | -0.4% |
| 売上前年比 | -2.0% | -0.0% |
| 純利益前年比 | 24.0% | -107.4% |
| EPS（希薄化後） | $0.33 | $0.02 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $28.9M | $32.0M | ||
| Q3 25 | $29.4M | $31.3M | ||
| Q2 25 | $31.4M | $30.7M | ||
| Q1 25 | $29.8M | $31.4M | ||
| Q4 24 | $29.5M | $32.0M | ||
| Q3 24 | $28.7M | $30.4M | ||
| Q2 24 | $27.4M | $31.0M | ||
| Q1 24 | $28.2M | $30.3M |
| Q4 25 | $-19.5M | $-120.0K | ||
| Q3 25 | $-17.8M | $618.0K | ||
| Q2 25 | $-18.5M | $1.9M | ||
| Q1 25 | $-25.8M | $2.5M | ||
| Q4 24 | $-25.6M | $1.6M | ||
| Q3 24 | $-27.9M | $2.3M | ||
| Q2 24 | $-34.5M | $2.7M | ||
| Q1 24 | $-39.9M | $3.0M |
| Q4 25 | 42.4% | — | ||
| Q3 25 | 39.4% | — | ||
| Q2 25 | 37.8% | — | ||
| Q1 25 | 37.2% | — | ||
| Q4 24 | 36.5% | — | ||
| Q3 24 | 34.3% | — | ||
| Q2 24 | 35.7% | — | ||
| Q1 24 | 29.2% | — |
| Q4 25 | -61.1% | -2.8% | ||
| Q3 25 | -53.7% | 4.3% | ||
| Q2 25 | -53.7% | 13.2% | ||
| Q1 25 | -55.1% | 15.4% | ||
| Q4 24 | -74.2% | 6.1% | ||
| Q3 24 | -83.2% | 14.6% | ||
| Q2 24 | -112.3% | 17.1% | ||
| Q1 24 | -131.0% | 19.5% |
| Q4 25 | -67.5% | -0.4% | ||
| Q3 25 | -60.6% | 2.0% | ||
| Q2 25 | -59.0% | 6.3% | ||
| Q1 25 | -86.7% | 7.9% | ||
| Q4 24 | -87.0% | 5.1% | ||
| Q3 24 | -97.5% | 7.4% | ||
| Q2 24 | -125.8% | 8.6% | ||
| Q1 24 | -141.8% | 9.9% |
| Q4 25 | $0.33 | $0.02 | ||
| Q3 25 | $-1.00 | $0.07 | ||
| Q2 25 | $-1.04 | $0.21 | ||
| Q1 25 | $-3.66 | $0.26 | ||
| Q4 24 | $-7.21 | $0.16 | ||
| Q3 24 | $-8.02 | $0.24 | ||
| Q2 24 | $-9.96 | $0.28 | ||
| Q1 24 | $-11.77 | $0.32 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $168.9M | $44.1M |
| 総負債低いほど良い | $96.2M | — |
| 株主資本純資産 | $127.0M | $50.3M |
| 総資産 | $264.5M | $166.6M |
| 負債/資本比率低いほどレバレッジが低い | 0.76× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $168.9M | $44.1M | ||
| Q3 25 | $178.6M | $36.1M | ||
| Q2 25 | $184.1M | $30.0M | ||
| Q1 25 | $189.0M | $36.3M | ||
| Q4 24 | $158.7M | $68.6M | ||
| Q3 24 | $175.6M | $58.1M | ||
| Q2 24 | $194.8M | $49.9M | ||
| Q1 24 | $226.9M | $39.7M |
| Q4 25 | $96.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $197.4M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $127.0M | $50.3M | ||
| Q3 25 | $142.4M | $58.9M | ||
| Q2 25 | $154.8M | $64.6M | ||
| Q1 25 | $169.9M | $80.0M | ||
| Q4 24 | $26.8M | $80.7M | ||
| Q3 24 | $47.8M | $84.6M | ||
| Q2 24 | $68.6M | $85.3M | ||
| Q1 24 | $93.2M | $83.9M |
| Q4 25 | $264.5M | $166.6M | ||
| Q3 25 | $277.3M | $157.6M | ||
| Q2 25 | $288.8M | $152.7M | ||
| Q1 25 | $301.2M | $159.9M | ||
| Q4 24 | $275.8M | $194.4M | ||
| Q3 24 | $292.9M | $184.2M | ||
| Q2 24 | $314.5M | $177.6M | ||
| Q1 24 | $346.2M | $170.2M |
| Q4 25 | 0.76× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.36× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-9.5M | $18.6M |
| フリーキャッシュフロー営業CF - 設備投資 | $-9.7M | $15.0M |
| FCFマージンFCF / 売上 | -33.7% | 46.9% |
| 設備投資強度設備投資 / 売上 | 0.8% | 11.4% |
| キャッシュ転換率営業CF / 純利益 | — | — |
| 直近12ヶ月FCF直近4四半期 | $-47.1M | $17.0M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-9.5M | $18.6M | ||
| Q3 25 | $-6.3M | $14.6M | ||
| Q2 25 | $-4.8M | $13.8M | ||
| Q1 25 | $-25.7M | $-24.7M | ||
| Q4 24 | $-16.5M | $21.6M | ||
| Q3 24 | $-20.6M | $13.3M | ||
| Q2 24 | $-33.3M | $16.0M | ||
| Q1 24 | $-45.9M | $-24.1M |
| Q4 25 | $-9.7M | $15.0M | ||
| Q3 25 | $-6.5M | $13.8M | ||
| Q2 25 | $-5.1M | $13.4M | ||
| Q1 25 | $-25.8M | $-25.1M | ||
| Q4 24 | $-16.5M | $19.9M | ||
| Q3 24 | $-21.0M | $12.9M | ||
| Q2 24 | $-33.5M | $15.6M | ||
| Q1 24 | $-46.3M | $-24.7M |
| Q4 25 | -33.7% | 46.9% | ||
| Q3 25 | -22.0% | 44.1% | ||
| Q2 25 | -16.3% | 43.6% | ||
| Q1 25 | -86.7% | -80.0% | ||
| Q4 24 | -56.1% | 62.2% | ||
| Q3 24 | -73.1% | 42.4% | ||
| Q2 24 | -122.2% | 50.4% | ||
| Q1 24 | -164.3% | -81.6% |
| Q4 25 | 0.8% | 11.4% | ||
| Q3 25 | 0.5% | 2.6% | ||
| Q2 25 | 0.9% | 1.5% | ||
| Q1 25 | 0.4% | 1.3% | ||
| Q4 24 | 0.1% | 5.3% | ||
| Q3 24 | 1.4% | 1.2% | ||
| Q2 24 | 0.4% | 1.1% | ||
| Q1 24 | 1.3% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 23.62× | ||
| Q2 25 | — | 7.22× | ||
| Q1 25 | — | -10.01× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 5.90× | ||
| Q2 24 | — | 6.00× | ||
| Q1 24 | — | -8.03× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
OM
| Consumables Product | $13.5M | 47% |
| Service And Other Revenue | $9.0M | 31% |
| Consoles Product | $6.4M | 22% |
SAMG
| Investment Advisory Management And Administrative Service | $30.7M | 96% |
| Tax And Family Office Services | $1.2M | 4% |
